ArticleInflammatory bowel diseases2024

Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease.

Elizabeth A Spencer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.